🇺🇸 FDA
Patent

US 8183285

Therapeutic agent for irritable bowel syndrome and methods thereof

granted A61KA61K31/343A61P

Quick answer

US patent 8183285 (Therapeutic agent for irritable bowel syndrome and methods thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/343, A61P, A61P1/00, A61P1/10